Insider trade

Officer sold ~$376K of AMGN shares in the open market

Traded Feb 19, 2026 · Filed Feb 21, 2026

AmgenAMGN

~$376K
Reported value · 1,000 sh @ $375.79: 3,423
Holds after · shares reported: +8.5%
stock since the trade · S&P 500 +11.6%, $375.50 → $407.27 on Oct 1

Why it stands out

Amgen's VP, Finance & CAO sold $376K of Amgen shares. It happened by itself, for taxes or pay.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Feb 19, 2026
Reporting period: Not applicable
Filed with the SEC: Feb 21, 2026

Officer$100K–$500KPre-arranged plan referenced

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$375,790

Shares × reported transaction price

Timing vs results

16 days after results of Feb 3, 2026, 70 days before results of Apr 30, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $375.50 on Feb 19, 2026, within 3% of its 52-week high, after a 14% rise over the previous 30 trading days

52-week range $262.28 (May 14, 2025) to $384.32 (Feb 6, 2026), 93% of the way up, from 251 adjusted closes. 30 trading days earlier: $330.17 on Jan 6, 2026. Describes the past only, not a forecast

Planned / mechanical clue

Footnote references dividend reinvestment

Only flagged when a footnote says so; never inferred

After it was reported

After	Stock	S&P 500	Difference
7 days	+1.7%	+0.6%	+1.1%
30 days	-6.7%	-3.8%	-3.0%
90 days	-11.5%	+10.0%	-21.4%
180 days	+17.0%	+11.9%	+5.1%

Past results only. Not a forecast.

Source receipt

Record ID: 0000318154-26-000011
Filed / recorded: Feb 21, 2026, 12:43 AM UTC
Added to OQRO: Oct 2, 2026, 12:27 PM UTC
Parser: form4-xml-v1
Data quality: Verified: identifiers matched exactly
Issuer: AMGEN INC
Issuer CIK: 318154
Ticker: AMGN
Reporting person: Matthew C. Busch
Relationship: Officer
Officer title: VP, Finance & CAO
Security: Common Stock
Table: Non-derivative (Table I)
Transaction date: Feb 19, 2026
Transaction code: S
Shares / units: 1,000
Price per share: $375.79
Acquired / disposed: Disposed (D)
Shares owned after: 3,423
Ownership form: Direct
Amendment: No

Footnotes from the filing

These shares include 60 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.